Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
暂无分享,去创建一个
Sofia Khan | D. Eccles | H. Nevanlinna | R. Fagerholm | Jianjun Liu | K. Aittomäki | C. Blomqvist | W. Tapper | L. Kadalayil
[1] Sofia Khan,et al. Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy , 2015, Clinical Cancer Research.
[2] Peter Kraft,et al. Identification of Novel Genetic Markers of Breast Cancer Survival , 2015, Journal of the National Cancer Institute.
[3] Qian Zhu,et al. Tissue-aware data integration approach for the inference of pathway interactions in metazoan organisms , 2015, Bioinform..
[4] P. Fasching,et al. The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients , 2015, Oncotarget.
[5] F. Couch,et al. A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis , 2014, PloS one.
[6] Yan Zhang,et al. Comparative analysis of pseudogenes across three phyla , 2014, Proceedings of the National Academy of Sciences.
[7] Y. Wu,et al. Regulation of autophagy by the Rab GTPase network , 2014, Cell Death and Differentiation.
[8] Masato Kimura,et al. NCBI’s Database of Genotypes and Phenotypes: dbGaP , 2013, Nucleic Acids Res..
[9] Andrea Sottoriva,et al. The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.
[10] F. Couch,et al. Identification of inherited genetic variations influencing prognosis in early-onset breast cancer. , 2013, Cancer research.
[11] M. Seabra,et al. Novel functions for Rab GTPases in multiple aspects of tumour progression , 2012, Biochemical Society transactions.
[12] S. Hamada,et al. The small GTPases Rab9A and Rab23 function at distinct steps in autophagy during Group A Streptococcus infection , 2012, Cellular microbiology.
[13] Raymond K. Auerbach,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[14] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[15] Zoltan Szallasi,et al. Jetset: selecting the optimal microarray probe set to represent a gene , 2011, BMC Bioinformatics.
[16] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[17] Yong-mei Yang,et al. RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells. , 2011, Gene.
[18] Anbupalam Thalamuthu,et al. A combined analysis of genome-wide association studies in breast cancer , 2011, Breast Cancer Research and Treatment.
[19] Rachel Schiff,et al. Mechanisms of endocrine resistance in breast cancer. , 2011, Annual review of medicine.
[20] Avi Ma'ayan,et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments , 2010, Bioinform..
[21] Z. Szallasi,et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.
[22] P. Pandolfi,et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.
[23] Xun Qu,et al. A novel tumor suppressor gene RhoBTB2 (DBC2): Frequent loss of expression in sporadic breast cancer , 2010, Molecular carcinogenesis.
[24] P. Schoenlein,et al. Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance , 2009, Autophagy.
[25] F. Rivero,et al. Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes--evidence for an autoregulatory mechanism. , 2008, Experimental cell research.
[26] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[27] D. Altman,et al. Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol , 2007, BMC Cancer.
[28] Takashi Yoshihara,et al. Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function. , 2007, Biochemical and biophysical research communications.
[29] Päivi Heikkilä,et al. Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients , 2005, International journal of cancer.
[30] K Holli,et al. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.
[31] H. Nevanlinna,et al. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? , 2000, European journal of cancer.
[32] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] R. Bernards,et al. CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.
[34] Massimo Cristofanilli,et al. Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer. , 2015, The New England journal of medicine.
[35] Melissa C. Greven,et al. An integrated encyclopedia of DNA elements in the human genome , 2014 .
[36] Tanya M. Teslovich,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[37] H. Nevanlinna,et al. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer , 2008, Breast Cancer Research and Treatment.
[38] Robert Clarke,et al. Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer. , 2005, Vitamins and hormones.
[39] Yusuke Nakamura,et al. A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese , 2022 .